EMA Medicine safety communications
Avtozma: medication error;quality defect
Published by European Medicines Agency:
Summary
Medication error;Quality defect
Medicine
Avtozma
- Category
- Medicine safety communications
- Product type
- Human medicine
- Active substance(s): tocilizumab
- Therapeutic area: Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection
- ATC code: L04AC07
Source: EMA — medicine safety communications — European Medicines Agency
Source: European Medicines Agency (EMA). Reproduced with acknowledgement of the source, in line with the EMA legal notice. EU Safety Radar is an independent information service; the text above presents the official data in the original language — the notice published by the authority is authoritative.
Open the original notice (www.ema.europa.eu) ↗